Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Health Insurance Innovations Inc    HIIQ

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Health Insurance Innovations, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/12/2017 | 12:32am CEST

Levi & Korsinsky announces it has commenced an investigation of Health Insurance Innovations, Inc. (“Health Insurance” or the “Company”) (NASDAQ:HIIQ) concerning possible violations of federal securities laws.

On September 11, 2017, an article was published on Seeking Alpha alleging, among other allegations, that: (1) in June 2017, one of the Company’s key license applications was rejected after regulators uncovered undisclosed legal actions against Company insiders; and (2) the Company privately warned a Florida regulator that a rejection of its license application could create a “domino effect” whereby licensing denials would spread to the other states. Following this news, shares of Health Insurance fell more than 18% to close at $23.35 per share on September 11, 2017. To obtain additional information, go to:

http://www.zlkdocs.com/HIIQ-Info-Request-Form-6098

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HEALTH INSURANCE INNOVATIO
09/23 Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in He..
09/22 ROBBINS ARROYO LLP : Health Insurance Innovations, Inc. (HIIQ) Misled Shareholde..
09/22 GLANCY PRONGAY & MURRAY LLP : Continues Investigation on Behalf of Health Insura..
09/21 HEALTH INSURANCE INNOVATIONS : Kirby McInerney LLP Announces That a Securities C..
09/21 HEALTH INSURANCE INNOVATIONS : Glancy Prongay & Murray LLP Commences Investigati..
09/21 HEALTH INSURANCE INNOVATIONS LEAD PL : Faruqi & Faruqi, LLP Encourages Investors..
09/21 Investigation of Health Insurance Innovations Announced by Holzer & Holzer
09/20 Levi & Korsinsky, LLP Notifies Shareholders of Health Insurance Innovations, ..
09/20 HEALTH INSURANCE INNOVATIONS INC : Pomerantz Law Firm Reminds Shareholders with ..
09/19 Khang & Khang LLP Announces a Securities Class Action Lawsuit against Health ..
More news
News from SeekingAlpha
09/12 Midday Gainers / Losers
09/12 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
09/12 Lake Street says bearish SA article a "rehash" of old news, recommends aggres..
09/12 PREMARKET LOSERS AS OF 9 : 05 am
09/11 HEALTH INSURANCE INNOVATIONS TO HOST : 30 pm ET
Financials ($)
Sales 2017 230 M
EBIT 2017 34,5 M
Net income 2017 19,2 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 13,88
P/E ratio 2018 11,51
Capi. / Sales 2017 1,55x
Capi. / Sales 2018 1,35x
Capitalization 358 M
Chart HEALTH INSURANCE INNOVATIO
Duration : Period :
Health Insurance Innovatio Technical Analysis Chart | HIIQ | US42225K1060 | 4-Traders
Technical analysis trends HEALTH INSURANCE INNOVATIO
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 38,7 $
Spread / Average Target 78%
EPS Revisions
Managers
NameTitle
Gavin C. Southwell President & Chief Executive Officer
Paul G. Gabos Non-Executive Chairman
Michael D. Hershberger Chief Financial Officer, Secretary & Treasurer
Sheldon X. Wang Chief Technology Officer
Michael W. Kosloske Director & Chief-Product Innovation
Sector and Competitors